Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.96 USD | +0.30% | -1.74% | +54.59% |
01:30pm | Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target | MT |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- NGNE Stock
- Revisions Neurogene Inc.